Generation of CD8+ T cell-generated suppressor factor and β- chemokines by targeted iliac lymph node immunization in rhesus monkeys challenged with SHIV-89.6P by the rectal route

AIDS Research and Human Retroviruses

Volumn 16, Issue 4, 2000, Pages 381-392

  Aubertin, Anne Marie ^a   Le Grand, Roger ^b   Wang, Yufei ^c   Beyer, Christian ^a   Tao, Louisa ^c   Neildez, Olivier ^b   Barré Sinoussi, Françoise ^d   Hurtrel, Bruno ^d   Moog, Christiane ^a   Lehner, Thomas ^c   Girard, Marc ^d,e  

^a INSERM   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INSTITUT PASTEUR   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; IMMUNOGLOBULIN A; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; SUPPRESSOR FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RECTUM MUCOSA; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HIV ANTIBODIES; ILIUM; IMMUNIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MALE; RECTUM; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SUPPRESSOR FACTORS, IMMUNOLOGIC; VIRAL LOAD;

EID: 0034090607     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309269     Document Type: Article

References (48)

1. 1. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PB, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
2. 2. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, van Rompay KKA, Reay E, Antipa L, Pedersen NC, and Marthas ML: A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 1994;69:7021-7029.
3. 3. Clements JH, Montelaro R, Zink C, Amadec A, Miller S, Trichel A, Jagerski B, Hauer D, Martin L, Bohen R, and Murphey-Corb M: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol 1995;69:2737-2744.
4. 4. Almond N, Kent N, Cranage M, Rud E, Clarke B, and Stott EJ: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995;345:1342-1344.
5. 5. Norley S, Beer B, Binninger-Schinzel D, Cosma D, and Kurth R: Protection from pathogenic SIVmac challenge following short term infection with a Nef-deficient attenuated virus. Virology 1996;219: 195-205.
6. 6. Wyand MS, Manson KH, Garcia-Moll M, Montefiori D, and Desrosiers RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol 1996;80:3724-3733.
7. 7. Shibata R, Sleman C, Czajak SC, Desrosiers RC, and Martin MA: Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J Virol 1997;71:8141-8145.
8. 8. Vogel TU, Fournier J, Sherring A, Ko D, Parenteau M, Bogdanovic D, Mihowich J, and Rud EW: Presence of circulating CTL induced by infection with wild-type or attenuated SIV and their correlation with protection from pathogenic SHIV challenge. J Med Primatol 1998;27:65-72.
9. 9. Langlois AJ, Desrosiers RC, Lewis MG, Kewalramani VN, Littman DR, Zhou JY, Manson K, Wyand MS, Bolognesi DP, and Montefiori DC: Neutralizing antibodies in sera from macaques immunized with attenuated simian imunodeficiency virus. J Virol 1998;72:6950-6955.
10. + T lymphocytes from macaques immunized with live attenuated SIV. J Virol 1998;72:6315-6324.
11. 11. Ahmed RKS, Nilsson C, Wang Y, Lehner T, Biberfeld G, and Thortensson R: β-Chemokine production in macaques vaccinated with live attenuated virus correlates with protection against SIVsm challenge. J Gen Virol 1999;80:1569-1574.
12. + lymphocytes can control HIV replication in vitro by suppressing virus replication. Science 1986;234:1563-1566.
13. + cells involves a nonlytic mechanism. J Virol 1991;65:5921-5927.
14. + T cells. Science 1995;270:1811-1815.
15. 15. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brokes R, Klavinskis L, Jones I, Doyle DC, and Ward R: Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med 1996;2:767-775.
16. 16. Reimann KA, Li JT, Voss G, Lekutis C, Tenner-Racz K, Racz P, Lin W, Montefiori DC, Lee-Parritz DE, Lu Y, Collman RG, Sodroski J, and Letvin NL: An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to achimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol 1996;70:3198-3206.
17. 17. Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, Sodroski J, and Letvin NL: A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 1996;70: 6922-6928.
18. 18. Kieny MP, Lathe A, Riviere Y, Dott K, Schmitt M, Girard M, Montagnier L, and Lecocq JP: Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng 1988;2:219-225.
19. 19. Lu X, Kiyono H, Lu D, Kowabata S, Torten J, Srinivasan S, Dailey PJ, McGhee JR, Lehner T, and Miller CJ: Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIV-mac251. AIDS 1998;12:1-10.
20. 20. Spouge JL: Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci USA 1992;89:7581-7585.
21. 21. Dunn CS, Hurtrel B, Beyer C, Gloeckler L, Ledger TN, Moog C, Kieny MP, Mehtali M, Schmitt D, Gut JP, Kirn A, and Aubertin AM: Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1. AIDS Res Hum Retroviruses 1997;11:913-922.
22. 22. Moog C, Fleury HJA, Pellegrin J, Kirn A, and Aubertin AM: Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol 1997;71:3734-3741.
23. 23. Spenlehauer C, Saragosti S, Fleury JHA, Kirn A, Aubertin A-M, and Moog C: Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell line-adapted strains of human immunodeficiency virus type 1. J Virol 1998;72:9855-9864.
24. 24. Ten Haaft P, Verstrepen B, Uberla K, Rosenwirth B, and Heeney J: A pathogenic threshold of virus load defined in simian immunodeficiency virus-, or simian-human immunodeficiency virus-infected macaques. J Virol 1998;72:10281-10285.
25. 25. Heeney J, Teeuwsen VJP, van Gils M, Bogers WMJM, de Giuli Morghen C, Radaelli A, Barnett S, Morein B, Akerblom L, Wang Y, Lehner T, and Davis D: β-Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc Natl Acad Sci USA 1998;95:10803-10808.
26. 26. Wang Y, Tao L, Mitchell E, Boggers WMJM, Sdoyle C, Bravery CA, Bergmeier LA, Kelly CG, Heeney JL, and Lehner T: Generation of CD8 suppressor factor and β-chemokines, induced by xenogenic immunization in the prevention of simian immunodeficiency virus infection in macaques. Proc Natl Acad Sci USA 1998;95:5323-5328.
27. 27. Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, and Franchini G: Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIVmac251: Dependence on route of challenge exposure. J Virol 1998;72:4170-4182.
28. 28. Leno M, Carter L, Venzon DJ, Romano J, Markham PD, Limbach K, Tartaglia J, Paoletti E, Benson J, Franchini G, and Robert-Guroff M: Lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy. AIDS Res Hum Retroviruses 1999;15:461-470.
29. 29. Mascola J, Lewis MG, Stiegler G, Harris D, van Cott TC, Hayes D, Louder M, Brown CR, Sappan CV, Frankel S, Lu Y, Robb M, Katinger H, and Birx D: Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6 PD by passive transfer of neutralizing antibodies. J Virol 1999;73:4009-4018.
30. 30. Polacino P, Stallard V, Montefiori DC, Brown CR, Richardson BA, Morton WR, Beneveniste RE, and Hu S-L: Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. J Virol 1999;73:3134-3156.
31. 31. Farzan M, Choe H, Martin K, Marcon L, Hofmann W, Karlsson G, Sun Y, Barrett P, Marchand N, Sullivan N, Gerard N, Gerard C, and Sodroski J: Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 1997;186:405-411.
32. 32. Rucker J, Edinger AL, Sharron M, Samson M, Lee B, Berson JF, Yi Y, Margulies B, Collman RG, Doranz BJ, Parmentier M, and Doms RW: Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997;71:8999-9007.
33. 33. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, McDonald ME, Stuhlmann H, Koup RA, and Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
34. 34. Samson M, Libert F, Doranz BJ, Rucker J, and Liesnard C: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature (London) 1996;382:722-725.
35. 35. Michael NL, Nelson JA, Kewal-Ramani VN, Chang G, O'Brien SJ, Mascola JR, Volsky B, Louder M, White GC II, Littman DR, Swanstrom R, and O'Brien TR: Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol 1998; 72:6040-6047.
36. 36. Yi Y, Rana S, Turner JD, Gaddis N, and Collman RG: CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1. J Virol 1998;72:772-777.
37. 37. Zhang Y-G and Moore JP: Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? J Virol 1999;73:3443-3448.
38. 38. Esté JA, Cabera C, Blanco J, Gutierrez A, Bridger G, Henson G, Clotet B, Schols D, and DeClercq E: Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J Virol 1999;73:5577-5585.
39. + T-cells: Role of signal transduction. Proc Natl Acad Sci USA 1998;95:11880-11885.
40. 40. Cheng Z, Zhou P, Ho DD, Landau NR, and Marx PA: Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-2714.
41. 41. Edinger AL, Amadee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu Z-H, Clements JE, Murphey-Corb M, Pepper SC, Parmentier M, Broder CC, and Doms RW: Differential utilization of CCR5 by macrophage- and T-cell tropic SIV strains. Proc Natl Acad Sci USA 1997;94:4005-4010.
42. 42. Marcon L, Choe H, Martin KA, Farzan M, Ponath PD, Wu L, Newman W, Gerard N, Gerard C, and Sodroski J: Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac 239. J Virol 1997;71:2522-2527.
43. 43. Deng H, Unutmaz D, Kewal-Ramani VN, and Liftman DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (London) 1997;388:296-300.
44. + cell noncytotoxic anti-HIV response. Proc Natl Acad Sci USA 1999;96:1030-1035.
45. 45. Joag SV, Stephens EB, Adams RJ, Foresman L, and Narayan O: Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: Effects of splenectomy on virus burden. Virology 1994;200:436-446.
46. 46. Johnson RP, Glickman RL, Yang JQ, Kaur A, Dion JT, Mulligan MJ, and Desrosiers RC: Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J Virol 1997;71:7711-7718.
47. 47. Matano T, Shibata R, Siemon C, Connors M, Lane CH, and Martin MA: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of SIV/HIV chimeric virus during primary infections of rhesus macaques. J Virol 1998;72:164-169.
48. + lymphocytes. Science 1999;283:857-860.